, ,

Why are there no clinical guidelines for kids with Long COVID?

Written by

–

Children with Long COVID pose on London’s Downing Street wearing matching white t-shirts that read “Long Covid Kids.” Three sit in wheel chairs while five stand beside them. They hold a support guide for pediatric Long COVID.
Children with Long COVID delivered a support guide to Prime Minster Boris Johnson earlier in the pandemic. Courtesy Long Covid Kids

Key points you should know:

  • Clinical guidelines, which establish standards of care, do not exist for children with Long COVID anywhere in the world.
     
  • Only one adult guideline includes a section on children and it does not provide advice on medications.
     
  • Six years into the pandemic, there are not enough healthcare services available for children with this devastating and disabling condition worldwide; many experience medical gaslighting. Parents are getting information about how to treat Long COVID from other parents on social media.
     
  • Few pediatricians and physicians specialize in Long COVID and they are overwhelmed by the demand.
     
  • Affected families are enraged and are mobilizing worldwide to consult with governments, create educational support systems, and lobby for greater investment in clinics that treat pediatric Long COVID.

It was tricky to tell Sophia and Isabelle apart when they were younger. They were 11-year-old identical twins from the West Midlands in the U.K. They went to school, ran around outside, and did everything together.

Since developing Long COVID two and a half years ago, Sophia has been using a feeding tube and an electric wheelchair. She can’t tolerate the smell or the taste of food. An hour of play with her sister takes her weeks to recover from. She’s started humming, tapping, and counting — repetitive behaviors that she didn’t have before COVID-19.

Jo, their mom, pans her phone camera so I can see her two daughters sitting next to her on the couch. Sophia buries her head in her mom’s side. “We always know when she’s had enough,” says Jo. “She starts to go rather lopsided.”

“I’m also a twin with Long COVID,” I tell them. I ask if the girls want to participate in the interview or just listen along. They go all shy. The camera slides back to Jo.

“They were one minute apart when they were born, but they’re no longer one minute apart,” says Jo. Sophia’s illness has also impacted her sister. “She lost her best friend,” says Jo.

Interviews with pediatricians, physicians, and patient advocates from the U.K., Australia, Italy, and the U.S. reveal a global emergency; in many countries, effective and affordable healthcare for children with Long COVID does not exist. Six years into the pandemic, there are no formal clinical guidelines for pediatric Long COVID anywhere in the world.

Six years into the pandemic, there are no formal clinical guidelines for pediatric Long COVID anywhere in the world.

By definition, clinical guidelines, which establish standards of care, must be based on robust studies. But there are only a handful of clinical trials underway in children with Long COVID.

There are guidelines for adults with Long COVID in the U.S., published by Bateman Horne Center in Utah, Mount Sinai in New York, and the virtual care clinic RTHM. Bateman Horne Center’s guidelines do have a chapter on children, but this chapter focuses on pacing, education, and accommodations and does not provide advice on medications.

Without formal clinical guidelines for kids, prescribing and disease management is trial and error — and falls into the problem-solving domain of specialists. But, across the globe, hundreds of clinics for Long COVID have lost funding and are closing down. Of those that are still open, few accept minors.

As a result, parents are left scrambling to find answers on social media and are forced to cobble together treatments from multiple private specialists — many of whom are hesitant to prescribe any of the drugs that are now used off-label to treat adults with Long COVID, regardless of how sick the child is.

This is if the physician even believes pediatric Long COVID is real. Based on reports from families worldwide, many physicians are uneducated on the biological mechanisms of the disease and refer children to psychologists, provide impractical and potentially dangerous advice like “go for a run,” or do nothing.

While estimates vary, it’s thought that as many as 20% of kids infected with SARS-CoV-2 develop Long COVID. A 2024 paper estimated that around 6 million kids in the U.S. are dealing with this life-altering condition.

Around the world, children with Long COVID are being neglected  by the medical system. Governments have turned a blind eye or are moving extremely slowly compared to the scale and severity of the crisis.

“It’s a failing on a massive scale,” said Jo. Even after six hospital admissions, “nothing was ever really done.” One doctor even told Jo point blank, “‘Don’t bring her back here. We haven’t got a clue what we’re doing.’”

More original Long COVID articles like this one, delivered to your inbox once a week

* indicates required

View previous campaigns

How clinical guidelines are created

Clinical guidelines usually take years to develop. They require a team of independent experts who perform a systematic evaluation of the research on treating a disease, come to a consensus, and write the guidelines.

Diseases typically have separate clinical guidelines for adults and kids, but the pediatric guidelines usually lag behind the adult guidelines because fewer clinical trials include children.

Often, pediatric clinical guidelines are broken down by three age groups. For example, the National Asthma Council’s Australian Asthma Handbook contains separate guidelines on the management of asthma in adults and adolescents, children aged 6–11, and children aged 1–5 years. The Royal Children’s Hospital in Melbourne has clinical guidelines for anaphylaxis that recommend different dosages of epinephrine at 1–5 years, 5–12 years, and 12 and over.

Pediatricians and physicians who specialize in treating Long COVID in children also have different approaches for these three age groups. Adolescents have similar body weights to adults, so the treatments for adults can be adapted easily in this age group.

For children under the age of 16 with lower body weights, physicians are more cautious about prescribing adult medications. They generally start with low doses and monitor side effects carefully.

But because there are no pediatric clinical guidelines for Long COVID anywhere in the world, many physicians have no idea how to treat the disease, and many Long COVID clinics turn children away.

There are four Long COVID clinics in California. Only one accepts children as patients — the Children’s Hospital Los Angeles. But “it is not offering any kind of therapy,” said Elham Raker, a pediatrician based in Los Angeles whose 16-year-old daughter, Darya, developed debilitating Long COVID four years ago.

Darya has seen physicians across three states — Alabama, Utah, and Colorado. “I learned everything [about Long COVID] from Facebook groups,” Raker said. Without a clinic, she served as both case manager and pediatrician.

I learned everything [about Long COVID] from Facebook groups.

Elham Raker, pediatrician and parent to a teenager with Long COVID

Doing nothing is not safe for kids

Waiting until there are large-scale drug trials before treating children with Long COVID does kids “a huge disservice,” said Michelle Scoullar, a pediatrician at Clinic Nineteen in Melbourne, Australia.

Most medications have been studied in children. “There are safety data available, even in young children, for most H1 and H2 antihistamines, propranolol, ivabradine, midodrine, low-dose naltrexone, sodium cromoglycate, ketotifen, and Singulair,” Scoullar said, naming medications often used off-label for Long COVID in adults.

Clinic Nineteen has seen children as young as five years of age with Long COVID and has prescribed off-label drugs for children as young as eight.

“When we start a medication it’s usually at — or below — the low end of dosing options, and we titrate slowly,” she said. “If there’s a side effect concern then we typically cease the medication and work through whether that symptom was disease- or medication-related, or some other possibility.”

Danilo Buonsenso, a pediatric infectious disease specialist at Gemelli University Hospital in Rome, Italy, similarly felt it was “not ethical to not offer anything” to adolescents with severe Long COVID.

In some cases, he has prescribed intravenous immunoglobulin, low-dose naltrexone, low-dose aripiprazole, and low-dose rapamycin. But he is more cautious with younger children; for them, “we mostly go with family education, school education, recognition, and symptomatic treatment,” Buonsenso said.

The lack of sustained, clear public health messaging from service providers and governments has entrenched a “deep-seated belief in the early false narrative” that children don’t get Long COVID, said Sammie McFarland, founder and CEO at Long COVID Kids, a charity based in the U.K.

With few pediatric trials so far, “children are a minority group within a minority group,” she said. But doing nothing is unacceptable when so many children are struggling, and there are immediate, common-sense steps that can be taken to help families, said McFarland.

In March 2020, McFarland and her then 14-year-old daughter both became ill with COVID-19 and went on to develop severe Long COVID. “We went from being active and able to being completely disabled and bedbound,” she said.

One healthcare professional told McFarland that her daughter was just mimicking her symptoms and would be fine when she got back to her friends. “Long COVID Kids was born from there,” she said.

With few pediatric trials so far, “children are a minority group within a minority group,” she said.

Sammie McFarland, founder and CEO at Long COVID Kids

We need pediatric Long COVID clinics

Primary care clinical guidelines for children with Long COVID need to be based on evidence, said Emma Tippett, an infectious disease physician and researcher at the Burnet Institute in Australia. “Otherwise, you need to leave that medicine to people who specialize in it.”

Ideally, pediatric Long COVID care would be provided by a publicly funded telehealth service rather than being viewed as the responsibility of primary care physicians who are “just never going to accumulate clinical experience with these off-label medications,” Tippett said.

Tippett founded the private telehealth service Clinic Nineteen in 2022. Within its first year, she contracted her first SARS-CoV-2 infection and went on to develop Long COVID herself. After that, she personally trialled all the drugs and supplements she could find that could plausibly help. (Disclosure: I’ve attended Clinic Nineteen since 2024, although Tippett is not my doctor.)

“The answers aren’t coming through mainstream medicine,” Tippett said. “And so people are doing their own research.”

Clinic Nineteen now has 16 physicians and has seen more than 1,600 patients with Long COVID, including around 100 children. The clinic started treating kids because parents were emailing to say they were desperate and could not find a physician to see their child.

“There is a general reluctance to prescribe to children,” Tippett said. “We strongly feel that withholding medications that may improve a child’s function and ability to engage in school or social activities is inexcusable. Especially for conditions such as POTS [postural orthostatic tachycardia syndrome] where the diagnosis is irrefutable, the therapeutics are simple, safe, and effective, and the impact can be life-changing.”

Clinic Nineteen is more likely to experiment with emerging medications like rapamycin in adults than in children. But the physicians will prescribe some off-label medications to children such as low-dose naltrexone, Tippett said.

More original Long COVID articles like this one, delivered to your inbox once a week

* indicates required

View previous campaigns

“A confusing and frightening time”

Charlotte, a 19-year-old in Australia who is a patient at Clinic Nineteen, was a voracious reader, a member of the debate club, and a public speaker who spent three hours a week dancing and two hours a week teaching dance before she caught COVID-19 three years ago.

“My life looks incredibly different to what it looked like pre-COVID,” Charlotte said. “I spend every single day in my room … If I’m lucky, I can only see my friends every three or four months. I can’t do any daily tasks by myself.”

Charlotte taught herself all the coursework for her final school exams. “It was the hardest thing I’ve ever had to do, but I did finish year 12, and I never attended a day of class,” she says. “I basically just sacrificed my entire social life to graduate school.”

Early in her illness, Charlotte saw a respiratory physician who told her cough was “probably just psychosomatic” and that she should see a therapist. A cardiologist also recommended that Charlotte try an unproven and often harmful treatment for Long COVID called graded exercise therapy, suggesting that she run for increasing time periods until she started to feel better.

Many leading guidelines for adults, including those published by the U.K.’s National Institute for Health and Care Excellence and the Bateman Horne Center, recommend against prescribing exercise for Long COVID and the often-overlapping disease myalgic encephalomyelitis (ME), especially when people have post-exertional malaise (PEM).

It was “such a confusing and frightening time … to not have any kind of direction or any guideline, even from your doctor,” Charlotte said. “I can’t imagine how it would be for young children who are feeling so scared.”

It wasn’t until Charlotte attended Clinic Nineteen that she started to get some answers. The physicians there are “always wanting to solve the problems, and really get down to the root cause and figure out what’s going on,” she said.

[It was] such a confusing and frightening time … to not have any kind of direction or any guideline, even from your doctor. I can’t imagine how it would be for young children who are feeling so scared.

Charlotte, 19-year-old with Long COVID

The lack of clinical guidelines is hard to fathom, said Henry, a 17-year-old with Long COVID in New South Wales, Australia, who is also a patient at Clinic Nineteen.

Earlier in his illness, Henry was twice asked by another clinic to run for as long as he could on a treadmill. He realized he’d caused serious damage when he reached the elevator. “Getting into the car was a struggle,” he said. It took him weeks to recover from PEM.

“Doctors have good intentions, but I think chucking a chronically ill kid on a treadmill isn’t the greatest of ideas,” he said.

Henry’s mother, Jen, also has Long COVID. Both she and Henry did not have any health issues before catching COVID-19. “I’ve tested places out before I’ve taken Henry,” she said. “I’ve probably protected him a little bit [from medical gaslighting].”

Clinic Nineteen has been “more slow and steady” with Henry than with Jen, but “I don’t see too much difference between what they’re treating Henry with and what they’ve treated me with,” she said.

Glimmers of hope

In Australia, the government has invested $1.1 million into creating new guidelines for adults with ME, which will be published in 2028.

These guidelines “are being developed on a shoestring” budget, said Anne Wilson, the CEO of Emerge Australia, a patient organization for ME, Long COVID, and related diseases. More investment would be needed for pediatric guidelines, she said. “However, we have already begun those discussions with key members of parliament and the Health Minister.”

Emerge Australia is joining forces with doctors’ associations and scientists to advocate for that funding.

Plus, for the first time since 2003, ME will be counted in the 2026 Australian Burden of Disease Study, which will help to bring this often-invisible illness out into the open

Meanwhile, in the U.K., Long COVID Kids has been working with the country’s Department for Education to develop guidance for supporting children with medical conditions and allergies at school, even if those children have not yet received a diagnosis.

In addition, the U.S. National Institutes of Health’s Long COVID clinical trials initiative, called RECOVER-Treating Long COVID, will soon be running the largest Long COVID pediatric clinical trial so far on low-dose naltrexone.

“So we’re moving in the right direction,” Wilson said. “Not fast enough for patients and families and carers … but the fact that we’ve got movement is something to be celebrated.”

Not fast enough for patients and families and carers … but the fact that we’ve got movement is something to be celebrated.

Anne Wilson, CEO of Emerge Australia

Felicity Nelson is a freelance science journalist based in Sydney, Australia.

All articles by The Sick Times are available for other outlets to republish free of charge. We request that you credit us and link back to our website.

More health stories

get the latest long covid news

Processing…
Success! You're on the list.
SpotifyApple PodcastsPocketCastsAmazon MusiciHeartRadio